|
Microparticles | Role in atherosclerosis | Reference |
|
PMPs | Enhance cyclooxygenase-2 (COX-2) and intracellular adhesion molecules-1 (ICAM-1) release. | [28] |
COX-2 expression in monocytes through translocation of protein kinase C (PKC) from cytosol to the cell membrane. | [29] |
Enhance the adhesion of monocyte to human umbilical vein endothelial cells. | [30] |
Increase WBC aggregation and assembly via expression of P-selectin. | [31] |
Neutrophil aggregation and enhance phagocytic activity. | [32] |
|
EMPs | CD-144/vascular endothelial cadherin positive. | [33] |
Reactive oxygen spices (ROS) formation. | [34] |
Matrix metalloproteinase-2 (MMP-2) activation and vascular matrix remodeling. | [35, 36] |
Reduce expression of p38-MAPK in human aortic endothelial cells caused reduction of TNF- induced EMPs. | [37] |
EMPs exhibit the TF activity in atherosclerotic plaques. | [38] |
Expression of E-selectin, ICAM-1, and VCAM-1. | [39] |
|
MMPs | Inducible nitric oxide synthase (iNOS) activation. | [40] |
Extracellular signal-regulated kinases (ERK1/2) activation. | [41] |
Procoagulant substances responsible for endothelial dysfunction. | [25] |
IL-1β in MMPs can enhance the vascular inflammatory. | [42] |
Atherosclerotic plaque formation in the ApoE mice. | [27] |
Increased expression of apoptosis regulator Bax, caspase-8, caspase-3, and cytochrome C in cardiomyocytes. | [43] |
Induce superoxide anion production, inflammatory cytokine release, and activation of NF-B gene in monocytes. | [44] |
|